KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Return on Sales: 2010-2025

Historic Return on Sales for Pacira BioSciences (PCRX) over the last 15 years, with Sep 2025 value amounting to 0.03%.

  • Pacira BioSciences' Return on Sales rose 16.00% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year increase of 16.00%. This contributed to the annual value of -0.14% for FY2024, which is 20.00% down from last year.
  • As of Q3 2025, Pacira BioSciences' Return on Sales stood at 0.03%, which was up 116.56% from -0.18% recorded in Q2 2025.
  • In the past 5 years, Pacira BioSciences' Return on Sales registered a high of 0.35% during Q2 2021, and its lowest value of -0.18% during Q2 2025.
  • Moreover, its 3-year median value for Return on Sales was -0.01% (2023), whereas its average is -0.03%.
  • Its Return on Sales has fluctuated over the past 5 years, first skyrocketed by 37bps in 2021, then decreased by 28bps in 2022.
  • Pacira BioSciences' Return on Sales (Quarterly) stood at 0.08% in 2021, then decreased by 5bps to 0.02% in 2022, then grew by 4bps to 0.06% in 2023, then declined by 20bps to -0.14% in 2024, then increased by 16bps to 0.03% in 2025.
  • Its Return on Sales stands at 0.03% for Q3 2025, versus -0.18% for Q2 2025 and -0.15% for Q1 2025.